Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis.

Nickens KP, Han Y, Shandilya H, Larrimore A, Gerard GF, Kaldjian E, Patierno SR, Ceryak S.

Biochim Biophys Acta. 2012 Feb;1823(2):264-72. doi: 10.1016/j.bbamcr.2011.10.005. Epub 2011 Oct 25.

2.

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.

Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Schmidt LS, Toro JR, Karami S, Hung R, Gerard GF, Linehan WM, Merino M, Zbar B, Boffetta P, Brennan P, Rothman N, Chow WH, Waldman FM, Moore LE.

Clin Cancer Res. 2008 Aug 1;14(15):4726-34. doi: 10.1158/1078-0432.CCR-07-4921.

3.

Pseudoxanthoma elasticum: genetic diagnostic markers.

Pfendner EG, Uitto J, Gerard GF, Terry SF.

Expert Opin Med Diagn. 2008 Jan;2(1):63-79. doi: 10.1517/17530059.2.1.63.

PMID:
23485117
4.

Development of a rapid, reliable genetic test for pseudoxanthoma elasticum.

Shi Y, Terry SF, Terry PF, Bercovitch LG, Gerard GF.

J Mol Diagn. 2007 Feb;9(1):105-12.

5.

A method for clone sequence confirmation using a mismatch-specific DNA endonuclease.

Qiu P, Shandilya H, Gerard GF.

Mol Biotechnol. 2005 Jan;29(1):11-8.

PMID:
15668515
6.

Thermophilic bacterial DNA polymerases with reverse-transcriptase activity.

Shandilya H, Griffiths K, Flynn EK, Astatke M, Shih PJ, Lee JE, Gerard GF, Gibbs MD, Bergquist PL.

Extremophiles. 2004 Jun;8(3):243-51. Epub 2004 Apr 9.

PMID:
15197605
7.

Mutation detection using Surveyor nuclease.

Qiu P, Shandilya H, D'Alessio JM, O'Connor K, Durocher J, Gerard GF.

Biotechniques. 2004 Apr;36(4):702-7.

8.
9.

Excess dNTPs minimize RNA hydrolysis during reverse transcription.

Gerard GF, Collins S, Smith MD.

Biotechniques. 2002 Nov;33(5):984, 986, 988 passim. No abstract available.

10.

The role of template-primer in protection of reverse transcriptase from thermal inactivation.

Gerard GF, Potter RJ, Smith MD, Rosenthal K, Dhariwal G, Lee J, Chatterjee DK.

Nucleic Acids Res. 2002 Jul 15;30(14):3118-29.

11.

Reverse transcriptase. The use of cloned Moloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA.

Gerard GF, Fox DK, Nathan M, D'Alessio JM.

Mol Biotechnol. 1997 Aug;8(1):61-77.

PMID:
9327398
12.

Reverse transcriptase (EC 2.7.7.49): the use of cloned maloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA.

Gerard GF, D'Alessio JM.

Methods Mol Biol. 1993;16:73-93. doi: 10.1385/0-89603-234-5:73. No abstract available.

PMID:
19082970
13.

Cloning and characterization of genes for the PvuI restriction and modification system.

Smith MD, Longo M, Gerard GF, Chatterjee DK.

Nucleic Acids Res. 1992 Nov 11;20(21):5743-7.

14.

Genetic organization of the KpnI restriction--modification system.

Chatterjee DK, Hammond AW, Blakesley RW, Adams SM, Gerard GF.

Nucleic Acids Res. 1991 Dec 11;19(23):6505-9.

15.

Cloning the KpnI restriction-modification system in Escherichia coli.

Hammond AW, Gerard GF, Chatterjee DK.

Gene. 1991 Jan 2;97(1):97-102.

PMID:
1995432
16.

Cloning and overexpression of the gene encoding bacteriophage T5 DNA polymerase.

Chatterjee DK, Fujimura RK, Campbell JH, Gerard GF.

Gene. 1991 Jan 2;97(1):13-9.

PMID:
1995424
17.

Characterization of NgoAIII, an isoschizomer of SstII from a strain of Neisseria gonorrhoea.

Hammond AW, Gerard GF, Chatterjee DK.

Nucleic Acids Res. 1989 Aug 25;17(16):6750. No abstract available.

18.

Characterization of a restriction enzyme from a strain of Neisseria gonorrhoea which recognizes 5'G/CCGGC3', an isoschizomer of NaeI.

Hammond AW, Gerard GF, Campbell JH, Chatterjee DK.

Nucleic Acids Res. 1989 Apr 25;17(8):3320. No abstract available.

20.
21.

Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.

Kotewicz ML, Sampson CM, D'Alessio JM, Gerard GF.

Nucleic Acids Res. 1988 Jan 11;16(1):265-77.

22.
23.

Amino- and carboxyl-terminal sequence of Moloney murine leukemia virus reverse transcriptase.

Copeland TD, Gerard GF, Hixson CW, Oroszlan S.

Virology. 1985 Jun;143(2):676-9.

PMID:
2414914
24.

Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli.

Kotewicz ML, D'Alessio JM, Driftmier KM, Blodgett KP, Gerard GF.

Gene. 1985;35(3):249-58.

PMID:
2412939
25.
26.
27.

Distribution of DNA polymerase Cm in normal and malignant human tissues.

Loewenstein PM, Lange GW, Gerard GF.

Cancer Res. 1980 Dec;40(12):4398-402.

28.

Characterization of a DNA polymerase activity in cultured human melanoma cells that copies poly(2'-O-methylcytidylate).

Gerard GF, Loewenstein PM, Green M.

J Biol Chem. 1980 Feb 10;255(3):1015-22. No abstract available.

29.
31.

Do normal human cells express RNA tumor virus-related information?

Gerard GF, Green M.

Prog Exp Tumor Res. 1978;21:250-69. Review. No abstract available.

PMID:
77030
32.

Studies on the DNA polymerase activity contained in particles released from human embryo cell monolayers.

Margalith M, Gerard GF, Green M.

Biochim Biophys Acta. 1976 Mar 17;425(3):305-15. No abstract available.

PMID:
1259973
33.

Inhibition of purified DNA polymerase of RNA tumor viruses by fluoranthene derivatives and analogues of tilorone hydrochloride.

Green M, Rankin A, Gerard GF, Grandgenett DP, Green MR.

J Natl Cancer Inst. 1975 Aug;55(2):433-42.

PMID:
51087
34.

Detection of reverse transcriptase in human breast tumours with poly(Cm)-oligo(dG).

Gerard GF, Loewenstein PM, Green M, Rottman F.

Nature. 1975 Jul 10;256(5513):140-3. No abstract available.

PMID:
50561
35.
37.

Biochemical suppression of tumor virus activity.

Green M, Gerard GF, Grandgenett DP, Gurgo C, Rankin AM, Green MR, Cassell DM.

Cancer. 1974 Oct;34(4 Suppl):suppl:1427-38. No abstract available.

PMID:
4138484
39.

RNA-directed DNA polymerase--properties and functions in oncogenic RNA viruses and cells.

Green M, Gerard GF.

Prog Nucleic Acid Res Mol Biol. 1974;14(0):187-334. Review. No abstract available.

PMID:
4135976
40.

Rifamycin derivatives: specific inhibitors of nucleic acid polymerases.

Gerard GF, Gurgo C, Grandgenett DP, Green M.

Biochem Biophys Res Commun. 1973 Jul 2;53(1):194-201. No abstract available.

PMID:
4126333
41.
42.

Ribonuclease H: a ubiquitous activity in virions of ribonucleic acid tumor viruses.

Grandgenett DP, Gerard GF, Green M.

J Virol. 1972 Dec;10(6):1136-42.

43.

Release of the sigma subunit of Pseudomonas putida deoxyribonucleic acid dependent ribonucleic acid polymerase.

Gerard GF, Johnson JC, Boezi JA.

Biochemistry. 1972 Mar 14;11(6):989-97. No abstract available.

PMID:
5013820
44.

Template activity of 2'-O-methylpolyribonucleotides with Pseudomonas putida DNA-dependent RNA polymerase.

Gerard GF, Rottman F, Boezi JA.

Biochem Biophys Res Commun. 1972 Feb 16;46(3):1095-101. No abstract available.

PMID:
5012160
45.

2'-O-methyladenosine 5'-triphosphate. A substrate for deoxyribonucleic acid dependent ribonucleic acid polymerase of Pseudomonas putida.

Gerard GF, Rottman F, Boezi JA.

Biochemistry. 1971 May 25;10(11):1974-81. No abstract available.

PMID:
4935104

Supplemental Content

Loading ...
Support Center